Literature DB >> 19216562

2-Acetylpyridine thiosemicarbazones are potent iron chelators and antiproliferative agents: redox activity, iron complexation and characterization of their antitumor activity.

Des R Richardson1, Danuta S Kalinowski, Vera Richardson, Philip C Sharpe, David B Lovejoy, Mohammad Islam, Paul V Bernhardt.   

Abstract

Through systematic structure-activity studies of the 2-benzoylpyridine thiosemicarbazone (HBpT), 2-(3-nitrobenzoyl)pyridine thiosemicarbazone (HNBpT) and dipyridylketone thiosemicarbazone (HDpT) series of iron (Fe) chelators, we identified structural features necessary to form Fe complexes with potent anticancer activity (J. Med. Chem. 2007, 50, 3716-3729). In this investigation, we generated the related 2-acetylpyridine thiosemicarbazone (HApT) analogues to examine the influence of the methyl group at the imine carbon. Four of the six HApT chelators had potent antitumor activity (IC(50): 0.001-0.002 microM) and Fe chelation efficacy that was similar to the most effective HBpT and HDpT ligands. The HApT Fe complexes had the lowest Fe(III/II) redox potentials of any thiosemicarbazone series we have generated. This property, in combination with their ability to effectively chelate cellular Fe, make the HApT series one of the most potent antiproliferative agents developed by our group.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19216562     DOI: 10.1021/jm801585u

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  25 in total

1.  Allele-specific p53 mutant reactivation.

Authors:  Xin Yu; Alexei Vazquez; Arnold J Levine; Darren R Carpizo
Journal:  Cancer Cell       Date:  2012-05-15       Impact factor: 31.743

2.  Trypanocidal and cytotoxic evaluation of synthesized thiosemicarbazones as potential drug leads against sleeping sickness.

Authors:  Bienvenu Glinma; Sika D S Kpoviessi; Fernand A Gbaguidi; Coco N Kapanda; Joanne Bero; Joëlle Quetin-Leclercq; Mansourou Moudachirou; Jacques Poupaert; Georges C Accrombessi; Emma W Gachomo; Lamine Baba-Moussa; Simeon O Kotchoni
Journal:  Mol Biol Rep       Date:  2014-01-10       Impact factor: 2.316

3.  Interaction of Triapine and related thiosemicarbazones with iron(III)/(II) and gallium(III): a comparative solution equilibrium study.

Authors:  Éva A Enyedy; Michael F Primik; Christian R Kowol; Vladimir B Arion; Tamás Kiss; Bernhard K Keppler
Journal:  Dalton Trans       Date:  2011-04-27       Impact factor: 4.390

Review 4.  Iron-targeting antitumor activity of gallium compounds and novel insights into triapine(®)-metal complexes.

Authors:  Christopher R Chitambar; William E Antholine
Journal:  Antioxid Redox Signal       Date:  2012-10-03       Impact factor: 8.401

Review 5.  Is resistance useless? Multidrug resistance and collateral sensitivity.

Authors:  Matthew D Hall; Misty D Handley; Michael M Gottesman
Journal:  Trends Pharmacol Sci       Date:  2009-09-15       Impact factor: 14.819

6.  Mechanistic studies of semicarbazone triapine targeting human ribonucleotide reductase in vitro and in mammalian cells: tyrosyl radical quenching not involving reactive oxygen species.

Authors:  Yimon Aye; Marcus J C Long; JoAnne Stubbe
Journal:  J Biol Chem       Date:  2012-08-22       Impact factor: 5.157

7.  Ribonucleotide reductase metallocofactor: assembly, maintenance and inhibition.

Authors:  Caiguo Zhang; Guoqi Liu; Mingxia Huang
Journal:  Front Biol (Beijing)       Date:  2014-01-02

8.  Iron Complexes of an Antiproliferative Aroyl Hydrazone: Characterization of Three Protonation States by Electron Paramagnetic Resonance Methods.

Authors:  Andrei V Astashkin; Rachel D Utterback; Yu-Shien Sung; Elisa Tomat
Journal:  Inorg Chem       Date:  2020-07-30       Impact factor: 5.165

9.  The Metastasis Suppressor, N-MYC Downstream-regulated Gene-1 (NDRG1), Down-regulates the ErbB Family of Receptors to Inhibit Downstream Oncogenic Signaling Pathways.

Authors:  Zaklina Kovacevic; Sharleen V Menezes; Sumit Sahni; Danuta S Kalinowski; Dong-Hun Bae; Darius J R Lane; Des R Richardson
Journal:  J Biol Chem       Date:  2015-11-03       Impact factor: 5.157

10.  Thiosemicarbazone-based selective proliferation inactivators inhibit gastric cancer cell growth, invasion, and migration.

Authors:  Biao Hu; Bo Wang; Bing Zhao; Qian Guo; Zhong-Hua Li; Xin-Hui Zhang; Guang-Yao Liu; Ying Liu; Ying Tang; Fan Luo; Ya Du; Ya-Xin Chen; Li-Ying Ma; Hong-Min Liu
Journal:  Medchemcomm       Date:  2017-10-23       Impact factor: 3.597

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.